GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

47.68USD
22 Aug 2014
Price Change (% chg)

$-0.02 (-0.04%)
Prev Close
$47.70
Open
$47.49
Day's High
$47.77
Day's Low
$47.41
Volume
2,703,562
Avg. Vol
3,127,994
52-wk High
$56.73
52-wk Low
$46.01

GSK

Chart for GSK

About

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in... (more)

Overall

Beta: 0.59
Market Cap (Mil.): $114,925.20
Shares Outstanding (Mil.): 2,424.76
Dividend: 0.65
Yield (%): 5.57

Financials

  GSK Industry Sector
P/E (TTM): 14.80 33.79 34.50
EPS (TTM): 3.22 -- --
ROI: 18.08 18.70 17.96
ROE: 75.85 19.28 18.65
Search Stocks

INDIA PRESS-GlaxoSmithKline looks to invest 10 bln rupees in new health drink unit - Economic Times

Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Derek Francis in Bangalore)

21 Aug 2014

GSK-linked investigators will not appeal China sentence: lawyer

SHANGHAI - British corporate investigator Peter Humphrey and his American wife Yu Yingzeng do not plan to appeal a Chinese court's decision to sentence them to prison, a lawyer told Reuters on Friday.

15 Aug 2014

GSK-linked investigators will not appeal China sentence-lawyer

SHANGHAI, Aug 15 - British corporate investigator Peter Humphrey and his American wife Yu Yingzeng do not plan to appeal a Chinese court's decision to sentence them to prison, a lawyer told Reuters on Friday.

15 Aug 2014

Exclusive: GlaxoSmithKline faces fresh drug bribery claims in Syria

LONDON - GlaxoSmithKline faces new allegations that it bribed Syrian doctors and officials to boost sales of its medicines, following recent accusations of corruption in its non-prescription business in the country.

11 Aug 2014

Clinical trial to start soon on GSK Ebola vaccine

* Drugmaker working on experimental vaccine with U.S. NIAID

10 Aug 2014

RPT-U.S. emergency labs ready to work on Ebola drugs if asked

(Repeating story first sent on Aug 9 to additional subscribers)

10 Aug 2014

U.S. emergency labs ready to work on Ebola drugs if asked

NEW YORK/WASHINGTON - All three U.S. facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.

09 Aug 2014

U.S. emergency labs ready to work on Ebola drugs if asked

NEW YORK/WASHINGTON, Aug 9 - All three U.S. facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.

09 Aug 2014

China sentences GSK-linked investigators to prison

SHANGHAI - China sentenced a British corporate investigator to 2-1/2 years in prison on Friday for illegally obtaining private records of Chinese citizens and selling the information on to clients including drugmaker GlaxoSmithKline Plc. | Video

08 Aug 2014

UPDATE 3-China sentences GSK-linked investigators to prison

* Unclear whether wife will also be forced to leave China

08 Aug 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks